Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis
JAC-Antimicrobial Resistance · 02.07.2025 · 7 (4)
DOI: 10.1093/jacamr/dlaf119 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 18.07.2025. Verfasst von Yalewayker Gashaw und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, College of Health Sciences, Woldia University, PO Box 400, Woldia, Ethiopia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Colistin resistance in multidrug-resistant (MDR) Klebsiella pneumoniae is a growing concern in Africa, complicating treatment and public health management. Colistin is a last-resort antibiotic for Gram-negative infections, but its resistance in clinical settings presents significant challenges. This study aims to determine the pooled prevalence of colistin resistance in MDR K. pneumoniae isolates from clinical specimens in Africa.
Methods
Articles were sourced from PubMed, Scopus, ScienceDirect and Google Scholar. Studies included were those reporting colistin resistance in MDR K. pneumoniae from clinical specimens in Africa, using EUCAST and CLSI-standard drug susceptibility testing. Data were extracted into Excel and analysed using STATA 17 with a random-effects model to determine the pooled prevalence. Heterogeneity was assessed using the I2 statistic, and publication bias was checked with Egger’s test. Subgroup analyses were performed to explore heterogeneity.
Results
The study analysed data from 30 articles on colistin resistance in MDR K. pneumoniae. The pooled prevalence was 21.59% (95% CI: 12.12–31.06), with high heterogeneity (I2 = 99.71%). Sub-regional variation was significant (P < 0.001), with prevalence rates differing across regions: 42.34% in East Africa, 37.1% in West Africa, 17.1% in Southern Africa and 13.0% in North Africa. Country-specific rates were highest in Nigeria (39.12%), followed by Kenya (22.52%), South Africa (17.12%) and Egypt (14.0%) (P < 0.001).
Conclusions
Colistin resistance in MDR K. pneumoniae is high in Africa, with notable regional differences. The study calls for strict colistin regulations, robust antimicrobial stewardship and rapid diagnostic tools for resistance detection.
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, College of Health Sciences, Woldia University, PO Box 400, Woldia, Ethiopia.
- Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Injibara University, Injibara, Ethiopia.
- Department of Medical Microbiology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
- Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Prinshof 0084, Pretoria, South Africa.
ORCID-Profile: Zelalem Asmare, Mitkie Tigabie, Melese Abate Reta
Zitieren
APA
Gashaw, Y., Asmare, Z., Sisay, A., Getachew, E., Gedfie, S., Ashagre, A., Bitew, G., Tigabie, M., & Reta, M. A. (2025). Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 7(4). https://doi.org/10.1093/jacamr/dlaf119
Vancouver
Gashaw Y, Asmare Z, Sisay A, Getachew E, Gedfie S, Ashagre A, et al. Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis. JAC-Antimicrobial Resistance. 2025;7(4). doi:10.1093/jacamr/dlaf119
BibTeX
@article{Gashaw2025,
author = {Gashaw, Yalewayker and Asmare, Zelalem and Sisay, Assefa and Getachew, Ermias and Gedfie, Solomon and Ashagre, Agenagnew and Bitew, Getachew and Tigabie, Mitkie and Reta, Melese Abate},
title = {Prevalence of colistin resistance in multidrug-resistant Klebsiella pneumoniae recovered from clinical samples in Africa: a systematic review and meta-analysis},
journal = {JAC-Antimicrobial Resistance},
year = {2025},
volume = {7},
number = {4},
doi = {10.1093/jacamr/dlaf119}
}
EUVIMED